Guttify, an India-based diagnosis-first gut health company, is planning to raise ₹20 crore in its next funding round as it looks to accelerate the development of a comprehensive consumer platform focused on gut wellness. The company’s latest funding round valued it at approximately ₹54 crore.

The proposed fundraise comes as gut health is gaining wider attention in India, with growing consumer awareness around digestion, metabolic health, the microbiome and preventive wellness. Guttify is currently reporting 67% quarter-on-quarter growth, around 20% monthly growth in its user base and a 40% repeat-user rate.

At the centre of Guttify’s strategy is its “Diagnosis-First” approach, which enables consumers to understand their gut health before moving towards personalised guidance and targeted wellness solutions. Its ₹399 DIY Gut Scan Kit has been used by more than 30,000 consumers and serves as an entry point for personalised recommendations, expert guidance and gut-wellness solutions.

The company is building an integrated gut-health ecosystem covering diagnosis, understanding, personalisation, management and maintenance. Its platform combines at-home diagnostics, personalised recommendations, expert guidance and clinically formulated solutions aimed at helping consumers better understand and manage digestive health.

The upcoming ₹20 crore fundraise will be used to accelerate product innovation, strengthen technology and diagnostic capabilities, invest in consumer education and expand distribution across Tier 1 and Tier 2 cities in India.

Also Read: New AI Tool Uses Deep Learning to Spot Hidden Cancer Cells

Guttify also plans to expand its portfolio across digestive and metabolic wellness areas, including constipation, bloating, digestion, liver health and everyday gut wellness. The proposed raise follows earlier funding rounds, with the company having raised more than ₹10 crore cumulatively from investors including the family office associated with Unichem Laboratories, existing investors and prominent Indian and international high-net-worth individuals.

With gut and metabolic wellness increasingly becoming part of mainstream consumer healthcare, Guttify aims to build a personalised, diagnosis-led platform that goes beyond conventional supplements and supports consumers throughout their long-term gut health journey.

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!